Lexis Nexis’s The Drugs and Cosmetics Act, 1940 (Bare Act) – 2021 Edition
Original price was: ₹695.00.₹530.00Current price is: ₹530.00.
Lexis Nexis’s The Drugs and Cosmetics Act, 1940 along with Rules, 1945 as amended by (Ninth Amendment) Rules, 2017 along with allied Act and Rules (Bare Act) – 2021 Edition. The Drugs and Cosmetics Act, 1940 (23 of 1940) with • The Drugs and Cosmetics Rules, 1945 as amended by (Twelfth Amendment) Rules, 2019 • The Drugs (Control) Act, 1950 Repealed by the Repealing and Amending Act, 2016 (23 of 2016).
Details
- Binding : Softcover
- Publisher : Lexis Nexis
- Author : Universal
- Edition : 2021
- Language : English
- ISBN-10 : D8
- ISBN-13 : D8
Related products
-
Add to cart
Taxmann’s flagship commentary on Direct Taxes, has been the most trusted & bestselling commentary for experienced practitioners, for more than 20 years now. This book aims at not only making the reader understand the law, but also helps the reader develop the ability to apply the law. In other words, this books aims at providing the reader the following: …
-
Read more
Taxmann’s GST Acts with Rules & Forms contains Amended, Updated & Annotated text of the following GST Act(s), Rules & Forms [as amended by the Finance Act 2021].
-
Read more
Taxmann’s Companies Act 2013 covers the Amended, Updated & Annotated text of the Companies Act, 2013 [as amended by the Companies (Amendment) Act 2020]. What sets it apart is the presentation/coverage of the Companies Act with corresponding Rules, Circulars & Notifications. In other words, the Annotation under each Section shows: Relevant Rules framed under the relevant Section Reference …
-
Read more
FEMA & FDI Ready Reckoner provides complete and accurate information about all provisions of the Foreign Exchange Management Act, 1999 (FEMA). It also includes guidance on all practical issues faced by companies and FEMA professionals. Key features of this book are as follows: Topic-wise commentary on FEMA Analysis of all provisions of FEMA with relevant …
Reviews
There are no reviews yet.